Specialty pharma company Accentia (ABPI) raised $19.2 million in an IPO through the sale of 2.4 million shares at $8, giving it a post-money valuation of $231 million. The underwriters were Jefferies; Ferris Baker Watts;...
In 2005, the size of a typical series A round has been $15.1 million - roughly 50% higher than previous years. August saw a flurry of even larger A rounds for preclinical companies, which is surprising...
Specialty pharma company Accentia (Tampa, Fla.) trimmed the shares and the price range of its IPO and now hopes to sell 2.5 million shares at $8-$10. A $9 deal price would raise $22.5 million and...
Specialty pharma company Accentia (Tampa, Fla.) amended its IPO and now hopes to sell 5.3 million shares at $11-$13. A $12 deal price would raise $63 million and value the company at $375 million. Underwriters...
Specialty pharma company Accentia (ABPI) raised $19.2 million in an IPO through the sale of 2.4 million shares at $8, giving it a post-money valuation of $231 million. The underwriters were Jefferies; Ferris Baker Watts;...
In 2005, the size of a typical series A round has been $15.1 million - roughly 50% higher than previous years. August saw a flurry of even larger A rounds for preclinical companies, which is surprising...
Specialty pharma company Accentia (Tampa, Fla.) trimmed the shares and the price range of its IPO and now hopes to sell 2.5 million shares at $8-$10. A $9 deal price would raise $22.5 million and...
Specialty pharma company Accentia (Tampa, Fla.) amended its IPO and now hopes to sell 5.3 million shares at $11-$13. A $12 deal price would raise $63 million and value the company at $375 million. Underwriters...